Wednesday, November 18, 2026
Science

Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.

Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice
Image: Phys.org
In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.

Originally published at Phys.org

The Morning Briefing

Subscribe to our Newsletter

Be the first to receive the latest news, market analysis and updates — delivered straight to your inbox.